Paul D. Thompson MD
Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut; Professor of Medicine –Emeritus, University of Connecticut, Storrs, ConnecticutPaul D. Thompson, MD, graduated from Tufts College and from Tufts Medical School. He served as a medical intern and resident at Tufts New England Medical Center and completed his training in cardiology at Stanford Medical Center.
Dr. Thompson is Chief of Cardiology – Emeritus, Hartford Hospital, Hartford, Connecticut, and Professor of Medicine – Emeritus at the University of Connecticut. He previously was Professor of Medicine at the University of Pittsburgh from 1992 to 1997 and on the faculty of Brown University from 1978 to 1992. He has authored over 500 scientific articles on topics which include: the treatment of cardiovascular risk factors, the effects of exercise training on preventing and treating heart disease; the risk of sudden death during exercise; the effects of statins on muscle function, and genetic factors affecting the exercise response. His past NIH funding includes the Preventive Cardiology Academic Award as well as studies examining the effect of exercise training on HDL metabolism; the effect of testosterone on endothelial function; genetic factors affecting muscle hypertrophy with exercise training; the effects of statins on skeletal muscle strength; the effects of Coenzyme Q10 on statin myalgia; and genetic factors increasing the risk of statin myalgia. Dr. Thompson is the Co-Editor of the book Exercise and Sports Cardiology and of the book Statin Associated Muscle Symptoms. He is a Past President of the American College of Sports Medicine.
Disclosures
Paul D. Thompson, MD, has received research support from Esperion and Norvartis; owns stock in Abbott Labs, CVS, Ilumina, Novo-Nordisk, GE Healthcare, Johnson & Johnson, Medtronic, Opsens, SCPharmaceuticals, Sarepta and Shockwave Medical; and has provided legal consultation on exercise-related cardiac events and statin myopathy.
Recent Contributions to PracticeUpdate:
- Cardiorespiratory Fitness Predicts Risk for Incidence of Heart Failure
- The Nocebo Effect Claims Statins Users
- Differential Plaque Formation in Masters Endurance Athletes vs Sedentary Men
- Lifelong Exercise Volume and Coronary Atherosclerosis in Athletes
- Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction
- AHA Advisory on Fish Oil Supplementation and the Prevention of Cardiovascular Disease
- Relationship Among Physical Activity, BMI, and Risk of Heart Failure
- Acute, Exercise Dose–Dependent Impairment in Atrial Performance During an Endurance Race
- Importance of Assessing Cardiorespiratory Fitness in Clinical Practice
- 2016 Top Stories in Cardiology: Exercise-Based Cardiac Rehabilitation